These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 26419264)

  • 1. Analyzing the potential for incorrect haplotype calls with different pharmacogenomic assays in different populations: a simulation based on 1000 Genomes data.
    Samwald M; Blagec K; Hofer S; Freimuth RR
    Pharmacogenomics; 2015; 16(15):1713-21. PubMed ID: 26419264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the accuracy of methods of computational haplotype inference using a large empirical dataset.
    Adkins RM
    BMC Genet; 2004 Aug; 5():22. PubMed ID: 15291970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomic knowledge representation, reasoning and genome-based clinical decision support based on OWL 2 DL ontologies.
    Samwald M; Miñarro Giménez JA; Boyce RD; Freimuth RR; Adlassnig KP; Dumontier M
    BMC Med Inform Decis Mak; 2015 Feb; 15():12. PubMed ID: 25880555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calling Star Alleles With Stargazer in 28 Pharmacogenes With Whole Genome Sequences.
    Lee SB; Wheeler MM; Thummel KE; Nickerson DA
    Clin Pharmacol Ther; 2019 Dec; 106(6):1328-1337. PubMed ID: 31206625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked differences in frequencies of statin therapy relevant SLCO1B1 variants and haplotypes between Roma and Hungarian populations.
    Nagy A; Sipeky C; Szalai R; Melegh BI; Matyas P; Ganczer A; Toth K; Melegh B
    BMC Genet; 2015 Sep; 16():108. PubMed ID: 26334733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-specific documentation of pharmacogenomic markers and their allelic frequencies in FINDbase.
    Georgitsi M; Viennas E; Gkantouna V; Christodoulopoulou E; Zagoriti Z; Tafrali C; Ntellos F; Giannakopoulou O; Boulakou A; Vlahopoulou P; Kyriacou E; Tsaknakis J; Tsakalidis A; Poulas K; Tzimas G; Patrinos GP
    Pharmacogenomics; 2011 Jan; 12(1):49-58. PubMed ID: 21174622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haplotype block partitioning and tag SNP selection using genotype data and their applications to association studies.
    Zhang K; Qin ZS; Liu JS; Chen T; Waterman MS; Sun F
    Genome Res; 2004 May; 14(5):908-16. PubMed ID: 15078859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic databases in pharmacogenomics: the Frequency of Inherited Disorders Database (FINDbase).
    Georgitsi M; Patrinos GP
    Methods Mol Biol; 2013; 1015():321-36. PubMed ID: 23824866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The global spectrum of protein-coding pharmacogenomic diversity.
    Wright GEB; Carleton B; Hayden MR; Ross CJD
    Pharmacogenomics J; 2018 Jan; 18(1):187-195. PubMed ID: 27779249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms of pharmacogenomic VIP variants in the Uygur population from northwestern China.
    Wang L; Aikemu A; Yibulayin A; Du S; Geng T; Wang B; Zhang Y; Jin T; Yang J
    BMC Genet; 2015 Jun; 16():66. PubMed ID: 26091847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of long-read sequencing to elucidate complex pharmacogenomic regions: a proof of principle.
    van der Lee M; Rowell WJ; Menafra R; Guchelaar HJ; Swen JJ; Anvar SY
    Pharmacogenomics J; 2022 Feb; 22(1):75-81. PubMed ID: 34741133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardized Biogeographic Grouping System for Annotating Populations in Pharmacogenetic Research.
    Huddart R; Fohner AE; Whirl-Carrillo M; Wojcik GL; Gignoux CR; Popejoy AB; Bustamante CD; Altman RB; Klein TE
    Clin Pharmacol Ther; 2019 May; 105(5):1256-1262. PubMed ID: 30506572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of
    Booyse RP; Twesigomwe D; Hazelhurst S
    Pharmacogenomics; 2022 Sep; 23(14):771-782. PubMed ID: 36043428
    [No Abstract]   [Full Text] [Related]  

  • 14. A pharmacogenomics primer.
    Court MH
    J Clin Pharmacol; 2007 Sep; 47(9):1087-103. PubMed ID: 17664254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining haplotype blocks and tag single-nucleotide polymorphisms in the human genome.
    Schulze TG; Zhang K; Chen YS; Akula N; Sun F; McMahon FJ
    Hum Mol Genet; 2004 Feb; 13(3):335-42. PubMed ID: 14681300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of HLA class II alleles and haplotypes in Mexican Mestizo population: comparison with other populations.
    Vargas-Alarcón G; Granados J; Rodríguez-Pérez JM; Parga C; Pérez-Hernández N; Rey D; Zuñiga J; Arnaiz-Villena A
    Immunol Invest; 2010 Jan; 39(3):268-83. PubMed ID: 20380523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selecting predictive markers for pharmacogenetic traits: tagging vs. data-mining approaches.
    Sabbagh A; Génin E; Darlu P
    Hum Hered; 2008; 66(1):10-8. PubMed ID: 18223313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying bias due to allele misclassification in case-control studies of haplotypes.
    Govindarajulu US; Spiegelman D; Miller KL; Kraft P
    Genet Epidemiol; 2006 Nov; 30(7):590-601. PubMed ID: 16830341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HapSim: a simulation tool for generating haplotype data with pre-specified allele frequencies and LD coefficients.
    Montana G
    Bioinformatics; 2005 Dec; 21(23):4309-11. PubMed ID: 16188927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accounting for haplotype uncertainty in matched association studies: a comparison of simple and flexible techniques.
    Kraft P; Cox DG; Paynter RA; Hunter D; De Vivo I
    Genet Epidemiol; 2005 Apr; 28(3):261-72. PubMed ID: 15637718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.